We are excited to collaborate with Biogen on litifilimab,” said Pablo Legorreta, Royalty Pharma’s founder and Chief Executive Officer. “Royalty Pharma offers tailored, win-win funding solutions for ...

Pablo Legorreta, CEO, highlighted strong 2024 performance, with Portfolio Receipts reaching $2.8 billion, at the high end of guidance and representing 13% growth in Royalty Receipts. He noted this ...

Amicus Therapeutics’ first oral drug for the rare condition Fabry disease has been approved by the FDA, giving patients an alternative to conventional injected enzyme replacement therapy.

Searchlight Pictures /Courtesy Everett Collection ©Searchlight Pictures/Courtesy Everett Collection Best Picture commentary (Updated Feb. 11, 2025): Sean Baker’s $6 million Palme d’Or winner ...

RICHMOND, Calif. - Sangamo Therapeutics, Inc. (NASDAQ: SGMO), a genomic medicine company with a market capitalization of $263 million, has announced promising updated results from its Phase 1/2 STAAR ...

Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...

Niday Picture Library / Alamy Stock Photo 24.Here's Hannes de Jong, the 1970 Pole Sitting World Champion, well, sitting on a pole: Yes, the World Pole Sitting Championship was a real thing.

PC hardware is nice, but it’s not much use without innovative software. I’ve been reviewing software for PCMag since 2008, and I still get a kick out of seeing what's new in video and photo ...

Best Picture commentary (Updated Feb. 5, 2025): This weekend, three major guilds — the Critics Choice Awards (whose final voting closed Jan. 10, before the whole “Emilia Pérez” drama), the ...

The pharmaceutical industry is at a pivotal moment. Artificial intelligence (AI) is shifting from improving processes to reshaping disease treatment and care delivery. Early adopters are seeing ...

We recently published a list of Jim Cramer Discusses These 11 Stocks & President Trump’s Sovereign Wealth Fund. In this ...